LabCorp 2010 Annual Report Download - page 51

Download and view the complete annual report

Please find page 51 of the 2010 LabCorp annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 52

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52

49
Corporate Headquarters
358 South Main Street
Burlington, NC 27215
336-584-5171
Information Sources
Information about LabCorp is available from
the following Company sources:
Investor Relations Contact
Stephen Anderson
Director, Investor Relations
336-436-5274
Center for Molecular Biology and Pathology
800-533-0567
Center for Occupational Testing
800-833-3984
Center for Esoteric Testing
800-334-5161
Paternity/Identity
800-742-3944
LabCorp Drug Development Laboratory
Services
888-244-4102
Web Site
www.LabCorp.com
Transfer Agent
American Stock Transfer & Trust Company
Shareholder Services
6201 Fifteenth Avenue
Brooklyn, NY 11219
800-937-5449
www.amstock.com
Independent Registered
Public Accounting Firm
PricewaterhouseCoopers LLP
800 Green Valley Road, Suite 500
Greensboro, NC 27408
Annual Meeting
The annual meeting of shareholders will be
held at 9.00 a.m. EDT on May 11, 2011 at
The Paramount Theater, 128 East Front Street,
Burlington, NC 27215.
Form 10-K
Copies of Form 10-K as filed with the Securities
and Exchange Commission are available
without cost to shareholders by writing to:
Laboratory Corporation of America Holdings
Investor Relations Department
358 South Main Street
Burlington, NC 27215
Safe Harbor
Forward-looking statements in this annual report
are subject to change based on various important
factors, including without limitation, competitive
actions in the marketplace and adverse actions
of governmental and other third-party payers.
Actual results could differ materially from those
suggested by these forward-looking statements.
Further information on potential factors which
could affect the Company’s financial results is
included in the Company’s Form 10-K for the year
ended December 31, 2010 and subsequent filings.
Common Stock
The Common Stock trades on the New York
Stock Exchange (“NYSE”) under the symbol
“LH”. The following table sets forth for the
calendar periods indicated the high and low
sales prices for the Common Stock reported
on the NYSE Composite Tape.
2010 2009
High Low High Low
1Q 77.09 69.49 65.90 53.25
2Q 83.00 73.12 68.09 57.08
3Q 78.94 71.58 71.29 62.06
4Q 89.48 75.75 76.74 63.81
L ABOR ATORY CORPORATION OF AMERICA
Shareholder and Company Information
Corporate Governance, Code of Business Conduct and Ethics – The Company’s Corporate Governance Guidelines, the Charters of its Audit Committee,
Compensation Committee, Quality and Compliance Committee, and Nominating and Corporate Governance Committee as well as the Company’s Code
of Business Conduct and Ethics are available on the Company’s Web Site at www.LabCorp.com. You can also obtain a hard copy of these documents,
without charge, upon written request to Stephen Anderson, Laboratory Corporation of America Holdings, 358 South Main Street, Burlington, NC 27215.
David P. King
Chairman and Chief Executive Officer
Kerrii B. Anderson 1,2
Former Chief Executive Officer and
President of Wendy’s International, Inc.
Jean-Luc Bélingard 2,3
Chairman, bioMérieux S.A.;
retired Chairman and CEO, Ispen S.A.
N. Anthony Coles, M.D., MPH 3
President and Chief Executive Officer of
Onyx Pharmaceuticals, Inc.
Wendy E. Lane 1,4
Chairman of Lane Holdings, Inc.,
an investment firm
Thomas P. Mac Mahon 3
Former Chairman and Chief Executive Officer of
Laboratory Corporation of America Holdings
Robert E. Mittelstaedt, Jr. 1,4
Dean and Professor, W.P. Carey School
of Business, Arizona State University
Arthur H. Rubenstein, MBBCh 1,3
Executive Vice President,
University of Pennsylvania Health System and
Dean of the School of Medicine
M. Keith Weikel, Ph.D. 2,3
Former Senior Executive Vice President and
Chief Operating Officer of HCR Manor Care, Inc.
R. Sanders Williams, M.D. 3,4
President of The J. David Gladstone Institutes
Committees:
1 Audit
2 Compensation
3 Quality and Compliance
4 Nominating and Corporate Governance
BOARD OF DIRECTORS EXECUTIVE MANAGEMENT
Dave King, Chairman and Chief Executive Officer
Jay Boyle, Executive Vice President,
Chief Operating Officer
Brad Hayes, Executive Vice President,
Chief Financial Officer
Andrew Conrad, Ph.D., Executive Vice President,
Chief Scientific Officer
*
Scott Walton, Executive Vice President,
Esoteric Businesses
Mark Brecher, M.D., Senior Vice President,
Chief Medical Officer
Lidia Fonseca, Senior Vice President,
Chief Information Officer
Sam Eberts, Senior Vice President,
Chief Legal Officer
Lisa Hoffman Starr, Senior Vice President,
Human Resources
* As of February 28th, 2011, Dr. Conrad transitioned into
a role as consultant and Chief Scientist for the Company.